IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
0.86
0.02 (2.19%)
At close: Aug 15, 2025, 9:53 AM
IceCure Medical Ltd Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 725K | 875K | 662K | 1.01M | 736.35K | 1.32M | 327K | 937K | 710K | 939K | 634K | 765K | 747K | 1.38M | 681K | 637K | 1.44M |
Cost of Revenue | 507K | 458K | 427K | 481K | 469.76K | 722.12K | 350K | 503K | 390K | 478K | 468K | 381K | 313K | 741K | 322K | 383K | 497K |
Gross Profit | 218K | 417K | 235K | 530K | 266.59K | 598.96K | -23K | 434K | 320K | 461K | 166K | 384K | 434K | 643K | 359K | 254K | 939K |
Operating Income | -3.66M | -4.53M | -4.29M | -3.23M | -3.62M | -3.59M | -4.12M | -4.08M | -3.96M | -3.93M | -4.1M | -4.28M | -4.42M | -3.13M | -2.85M | -2.55M | -1.19M |
Interest Income | 69K | n/a | n/a | 147K | 41K | 442.11K | 120.5K | 188.75K | 185.31K | 20K | 43K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.59M | -4.48M | -4.15M | -3.08M | -3.58M | -3.15M | -4M | -3.89M | -3.77M | -3.95M | -4.06M | -4.52M | -4.45M | -3.16M | -2.89M | -2.48M | -1.37M |
Net Income | -3.59M | -4.48M | -4.15M | -3.08M | -3.58M | -3.15M | -4M | -3.89M | -3.58M | -3.97M | -4.01M | -4.76M | -4.47M | -3.16M | -2.89M | -2.48M | -1.37M |
Selling & General & Admin | 2.21M | 3.25M | 2.66M | 2.17M | 1.95M | 2.1M | 1.9M | 2.44M | 2.17M | 2.16M | 2.03M | 2.41M | 2.46M | 2.17M | 1.66M | 1.22M | 988K |
Research & Development | 1.66M | 1.7M | 1.86M | 1.58M | 1.93M | 1.98M | 2.2M | 2.08M | 2.11M | 2.24M | 2.24M | 2.25M | 2.39M | 1.6M | 1.55M | 1.59M | 1.14M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.88M | 4.94M | 4.53M | 3.76M | 3.88M | 4.19M | 4.1M | 4.51M | 4.28M | 4.39M | 4.27M | 4.67M | 4.86M | 3.77M | 3.21M | 2.81M | 2.13M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K | n/a | 240K | 22K | n/a | 38K | n/a | 178K |
Selling & Marketing Expenses | 1.29M | 2.25M | 1.75M | 1.26M | 1.04M | -2.02M | 981K | 1.18M | 1.07M | -1.06M | 705K | 786K | 747K | 700K | 592K | 327K | 298K |
Cost & Expenses | 4.38M | 5.4M | 4.96M | 4.24M | 4.35M | 4.92M | 4.45M | 5.02M | 4.67M | 4.87M | 4.74M | 5.05M | 5.17M | 4.51M | 3.53M | 3.19M | 2.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 43.56K | n/a | n/a | -189K | 20K | -43K | 240K | 22K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.64M | 55.55M | 52.39M | 49.23M | 46.74M | 45.68M | 45.62M | 45.62M | 45.62M | 37.61M | 36.83M | 36.81M | 36.81M | 32.9M | 31.9M | 28.65M | 20.74M |
Shares Outstanding (Diluted) | 57.64M | 55.55M | 52.39M | 49.23M | 46.74M | 45.68M | 45.62M | 45.62M | 45.62M | 37.61M | 36.83M | 36.81M | 36.81M | 32.9M | 31.9M | 28.65M | 20.74M |
EPS (Basic) | -0.06 | -0.09 | -0.08 | -0.06 | -0.08 | -0.07 | -0.09 | -0.09 | -0.08 | -0.11 | -0.11 | -0.13 | -0.12 | -0.1 | -0.09 | -0.09 | -0.07 |
EPS (Diluted) | -0.06 | -0.09 | -0.08 | -0.06 | -0.08 | -0.07 | -0.09 | -0.09 | -0.08 | -0.11 | -0.11 | -0.13 | -0.12 | -0.1 | -0.09 | -0.09 | -0.07 |
EBITDA | -3.57M | -4.44M | -4.21M | -3.15M | -3.56M | -3.33M | -4.04M | -4M | -3.88M | -3.86M | -4.03M | -4.23M | -4.37M | -3.09M | -2.81M | -2.53M | -1.17M |
EBIT | -3.66M | -4.53M | -4.29M | -3.23M | -3.65M | -3.42M | -4.12M | -4.08M | -3.96M | -3.93M | -4.1M | -4.28M | -4.42M | -3.13M | -2.85M | -2.55M | -1.19M |
Depreciation & Amortization | 89K | 82K | 83K | 82K | 84.24K | 87.37K | 80.33K | 77.66K | 77.46K | 74K | 70K | 52K | 52K | 41K | 36K | 27K | 23K |